The GnRH receptor and the response of gonadotrope cells to GnRH pulse frequency code. A story of an atypical adaptation of cell function relying on a lack of receptor homologous desensitization. by Counis, Raymond et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(5): S81 (S81-S87) 
10.2478/v10042-009-0109-9
Introduction
The hypothalamic decapeptide gonadotropin-releas-
ing hormone (GnRH) is the neurohormone that medi-
ates brain control of the reproductive system. GnRH
acts through a specific seven-transmembrane-span-
ning receptor (GnRHR) expressed at the surface of
anterior pituitary gonadotropes to trigger the synthe-
sis and release of the two gonadotropins, LH and
FSH, which in turn regulate gonadal gametogenesis
and steroidogenesis. Accordingly, the mechanisms
underlying both GnRH release and action have been
the subject of intensive research during the past
decades. GnRH is produced in neuronal cells bodies
primarily located in the preoptic area of hypothala-
mus and is released in a pulsatile manner into the por-
tal vasculature of the median eminence-pituitary stalk
through which it reaches the pituitary gonadotropes.
As the final output of a complex neuronal network,
the GnRH neurons integrate a myriad of endogenous
and external signals resulting in a fine-tuned modula-
tion of the pulse frequency pattern [1]. Because the
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Abstract: Brain control of the reproductive system is mediated through hypothalamic gonadotropin-releasing hormone
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gonadotrope cell response is highly sensitive to these
frequency fluctuations, this creates a unique mode of
neuroendocrine regulation. Indeed, it is well estab-
lished that marked modifications in GnRH pulse pro-
files account for the differential changes in LH and
FSH secretion profiles over the course of the ovarian
cycle. In particular, the midcycle gonadotropin surge
which is essential for initiating ovulation results from
an abrupt and considerable rise in the GnRH pulse
secretion that is even maintained beyond the LH dis-
charge [2-4].
Interestingly, GnRH pulse frequency also influ-
ences gonadotropin synthesis. Both LH and FSH are
heterodimers resulting from the noncovalent associa-
tion of a common α- and a specific LHβ- or FSHβ-
subunit and all three subunits are encoded by a single
gene [5]. It is now established that low frequencies
preferentially increase transcription of the FSHβ
gene whereas higher frequencies favor the LHβ and
α-subunit genes [6,7]. On the other hand, sustained
GnRH causes a more or less rapid depletion of both
FSHβ and LHβ mRNA due to transcription arrest
associated with transcript degradation. Contrasting
with β-counterparts, the α-subunit mRNA levels
remain essentially constant or even increases slightly
for days [8-10]. These observations are consistent
with current clinical studies showing that long-term
administration of GnRH superagonists readily
induced depletion of LH and FSH but increased free
α-subunit levels in the serum of treated patients [11].
How physiological fluctuations of GnRH pulse pat-
terns or drastic pharmacological treatments are
decoded by the gonadotrope cell machinery to ulti-
mately alter gonadotropin secretion and/or gene tran-
scription has generated substantial, constantly
renewed interest. Internalization and homologous
desensitization of the GnRHR has been repeatedly
invoked to explain the repressive effects of sustained
stimulation. However, this idea is not supported by
the fact that some genes are rapidly inactivated while
some others remain readily activated. Furthermore,
princeps studies early suggested that the GnRHR
only poorly internalized [12].
The discovery that the mammalian GnRHR has
lost the carboxy-terminal tail that is usually involved
in classical endocytotic process of G protein-coupled
receptors (GPCR) and does not desensitize properly
provides an opportunity to reconsider our current
vision of the mechanisms by which gonadotropes
decode GnRH pulse frequency. Herein, we speculate
that the lack of GnRHR homologous desensitization
should confer to gonadotrope cells a unique feature
i.e. the ability to respond to short but also to pro-
longed exposures of GnRH through differential
mobilization of a diversity of intracellular mecha-
nisms.
The GnRH receptor activates a network
of signaling pathways and regulates a stream
of genes differentially sensitive to GnRH pulse
frequency
It has long been established that the GnRHR belongs
to the superfamily of GPCR (13]. In the pituitary gland
it is expressed only in the gonadotropes [14]. Upon lig-
and binding, the activated GnRHR preponderantly
couples with Gαq/11 and consequently stimulates
phospholipase Cβ (PLC). This induces the generation
of diacylglycerols and inositol-triphosphates (IP3)
which are responsible for the activation of several pro-
tein kinase C (PKC) isoforms and mobilization of
intracellular Ca2+, respectively. This process, in con-
junction with the massive entry of Ca2+ through volt-
age-dependent or -independent channels, is primarily
involved in acute gonadotropin release [15]. GnRH
also induces activation of the mitogen associated pro-
tein kinase (MAPK) cascade through PKC to stimulate
the expression of gonadotropin subunit genes [16,17].
Moreover, the GnRH-stimulated elevation of intracel-
lular Ca2+ causes activation of the NO synthase type I
(NOS I) cascade (NOS I/NO/soluble guanylate
cyclase) resulting in a rapid production of cGMP
[18,19]. GnRH can also generate cAMP, albeit maxi-
mal cAMP accumulation is much weaker and delayed
as compared to cGMP. The mechanisms underlying
activation of adenylate cyclase in gonadotropes have
long remained obscure. Recent data suggest the contri-
bution of novel PKC isoforms in this process [20] in
addition to the direct coupling through Gαs [21].
Cyclic AMP stimulates the expression of LH subunit
genes as well as the release of newly synthesised LH
[22-24]. Collectively, these data indicate that GnRH
induces a complex network of intracellular signaling
pathways with different kinetics to activate or inhibit
gonadotrope functions.
In addition, we and others have demonstrated that
GnRH action on the gonadotropes is associated with
an increasing complexity regarding gene regulation
and cell function. Indeed, gonadotropin subunit genes
are far from being the only genes affected by GnRH.
Instead, a still growing number of additional genes has
been identified using classical or more recent
approaches such as high throughput screening [25].
Several of these genes are members of the GnRHR
signaling network. These include, notably, the GnRHR
itself [10,26], NOS I [27,28], PKA [29] and PKC [30]
isoforms as well as transcription factors such as ATF3
[31], NUR77 [32] and EGR-1 [24], or autocrine/
paracrine factors such as activin and follistatin. Regu-
lation of these genes by GnRH appeared to be mediat-
ed through two or more signaling pathways. Unex-
pectedly, a majority of these genes are extremely
dependent on GnRH pulse frequency as mentioned
above for the gonadotropin β subunit genes. For
S82 R. Counis et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(5): S82 (S81-S87) 
10.2478/v10042-009-0109-9
instance, the GnRHR gene responded better to relative-
ly high GnRH frequencies, in the range of those
required for LHβ activation whereas a rapid although
incomplete inactivation was observed at higher frequen-
cies or under sustained GnRH stimulation [10,33]. In
contrast, a few genes among which are the prototypic α-
subunit and the most recently identified NOS I, exhibit-
ed resistance to the inhibitory effects of protracted
GnRH [27], further strengthening the idea that robust
and/or prolonged stimulation of gonadotrope cells do
not rapidly lead to a general cell desensitization. The
fact that GnRH regulates most of its signaling entities in
a manner highly dependent on the pulse frequency code
is one of the key mechanisms allowing the appropriate
adaptation of gonadotrope responsiveness.
Evidence that the lack of a C-terminal tail
confers an unusual resistance to
internalization and desensitization
of the mammalian GnRHR
While molecular cloning has confirmed that the mam-
malian GnRHR possessed the structural features of clas-
sical GPCRs, it also revealed a striking difference, the
lack of a cytoplasmic C-terminal tail [34]. Indeed, this
intracellular extension, present in all other GPCRs, is a
target for GPCR kinases allowing the recruitment of β-
arrestin that initiates the endocytic processing of recep-
tor/ligand complex via clathrin-coated pits [35,36].
Interestingly, the non-mammalian GnRH receptors
which have been discovered later, do exhibit a C-termi-
nal tail with structural and functional characteristics
shared by the GPCR family [34,37]. The comparison of
the internalizing properties of these two types of
GnRHR either in normal pituitary tissues or in heterol-
ogous cell systems demonstrated that the C-ter possess-
ing GnRHR internalized more rapidly and to a much
greater extent than those lacking a tail. Moreover,
adjunction of a C-terminal tail derived from any non-
mammalian GnRHR or other GPCR readily restored
internalizing properties to mammalian GnRHR [38,39].
All these studies were based on detection of labeled
GnRH interacting with native or chimeric GnRHR.
More recently, similar investigations were conducted
using an epitope-tagged receptor allowing the direct
analysis of the receptor molecule. This novel approach
established that the mammalian GnRHR exhibits a low
level of internalization either in absence or presence of
GnRH, demonstrating the occurrence of a weak, consti-
tutive agonist-independent internalization [40]. The
notion that mammalian GnRHRs do not internalize and
desensitize in response to ligand binding is further rein-
forced by studies from McArdle's group showing that a
β-arrestin-green fluorescent protein fusion protein
expressed in gonadotrope cells cannot undergo translo-
cation from cytoplasm to membrane after activation of
the mammalian GnRHR [41].
Decoding the GnRH pulse frequency code
through the mammalian GnRHR
The mammalian GnRHR thus appears as an atypical
GPCR able to confer hormonal selectivity and signal
transduction to gonadotropes while not exhibiting
internalization. This creates a peculiar situation in
which post-receptor mechanisms are predominantly
concerned in interpreting the wide range of GnRH
pulse frequencies. In particular, one can speculate that
at least some of the GnRH activated genes may con-
tribute to the dual process of activation/inactivation of
gonadotropin secretion.
Two mechanisms for the regulation of the LHβ and
FSHβ genes have been described to date that support
the above vision of GnRH action. Indeed, the deci-
phering of combinatorial codes of transcription factors
regulating the promoter activity of gonadotropin sub-
unit genes has assigned an important role to the
nuclear phosphoprotein EGR-1 (early growth response
protein-1) in gonadotrope-specific as well as GnRH-
induced expression of the LHβ gene [42,43]. EGR-1,
also known as NGFI-A (nerve growth factor-induced
protein A), acts in concert with the other transcription
factors SF-1, the pituitary homeobox PITX and, at
least in rodents, SP1, to regulate LHβ promoter activ-
ity. Interestingly, while GnRH activation of the LHβ
gene is mediated through the rapid induction of the
Egr-1 gene, its inactivation is initiated under sus-
tained stimulation through the delayed rise of EGR-1
co-repressor NAB (NGFI-A binding) proteins, NAB1
and NAB2 [44,45]. Contrasting with Nab1, Nab2
expression is readily amplified as EGR-1 increases
due to the presence of multiple EGR-1 elements with-
in its gene promoter. This suggests that NAB2 is the
most important EGR-1 regulator, crucial for establish-
ing the negative feedback loop involved in the GnRH
regulation of LHβ transcription [46]. Fig. 1 illustrates
the counteracting effects of such sequential induction
of Egr-1 and Nab genes on LHβ expression, empha-
sizing the progressive induction of NAB proteins as
the frequency of the GnRH stimulation is increased,
leading to complete inactivation of LHβ under pro-
longed GnRH exposure. A rather similar system based
on the sequential activation of another couple of func-
tionally complementary genes, i.e. activin and follis-
tatin, has been described in the rat for FSHβ [7,47,48].
In this species, GnRH at low frequencies durably
enhanced FSHβ gene expression via induction of the
activin gene. By contrast, higher frequencies induced
the co-expression of the follistatin gene leading to the
neutralization of activin by follistatin thereby turning-
off the GnRH stimulatory effects on FSHβ. 
These two examples well illustrate the manner by
which the profile of GnRH secretion may differential-
ly affect LH or FSH expression with a transcription
decline for both β-subunit genes in response to
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Fig. 1. Proposed model for neurohormonal regulation of the LH beta gene: an autoregulatory feedback loop feedback loop based on selec-
tive activation of Egr-1 and Nab genes mediates the high sensitivity of LHβ gene expression to the GnRH pulse frequency code. 
A. Schematic representation of the proximal 140-bp region of the LHβ gene promoter illustrating in different mammalian species the posi-
tional conservation of two EGR-1 elements in tandem with two SF-1 (steroidogenic factor-1) elements. e, equine; b, bovine; h, human; m,
mouse, r, rat. Δ51, sequence deletion in base pairs. B-C: Differential mechanisms for GnRH action depending on changes in the pulse fre-
quencies. B. Short individual GnRH pulses. GnRH transiently stimulates gonadotropes leading to the rapid PKC/MAPK-mediated activa-
tion of the primary target gene Egr-1. The resulting immediate production of EGR-1 factor is sufficient to induce, in concert with other
members of the transcription code, a weak transactivation of the LHβ gene associated with a modest LHβ-subunit production and thus, gen-
eration of the α/β LH dimer. In this pulsatile mode, suppression of GnRH is sufficient to reset promoter activity to basal level during the
interpulses. C. Robust and prolonged GnRH stimulation typified by proestrus of the ovarian cycle. Initially, highly repetitive GnRH puls-
es cause strong stimulation of the Egr-1 gene with a consequent high production of EGR-1 protein. This results in a robust stimulation of
the LHβ gene promoter and an ensuing marked production of LH as transcription and synthesis of the α-subunit is not limitating in
gonadotropes. The ongoing GnRH stimulation induces a delayed activation of the Nab1 and Nab2 genes, leading to the progressive accu-
mulation of the EGR-1 corepressors NAB proteins. NAB proteins dimerize with EGR-1 through conserved domains leading to neutraliza-
tion of the EGR-1 transactivating potency. Interestingly, in contrast to Nab1, Nab2 expression is readily amplified as EGR-1 levels increase
because the Nab2 gene promoter contains multiple EGR-1 cis-elements. This peculiarity confers to NAB2 a crucial regulatory role in the
negative feedback loop depicted in the figure. Compared to the "early stimulatory phase" where EGR-1 production is predominant, the pre-
dominance of NAB ultimately leads to complete neutralization of EGR-1. This results in abolition of the stimulatory effects of EGR-1 on
the LHβ gene ("final stimulatory phase"). In this system, the cAMP pathway would be preferentially operative in inactivation processes.
increasing GnRH frequencies but with a distinct
threshold of sensitivity as mentioned earlier.
Interestingly, several genes including Egr-1 can be
activated in gonadotropes through multiple signaling
systems, i.e. PKC, MAPK as well as the cAMP/PKA
pathway [24]. Such a complex signaling could reflect
redundancy or may be necessary for a coordinate reg-
ulation of cell functions. As mentioned above, while
the former two pathways respond very rapidly to
GnRH the latter, i.e. the cAMP/PKA pathway, reacts
more progressively. This strengthens the idea that the
cAMP/PKA signaling pathway would be preferential-
ly operative under sustained GnRH stimulation. More-
over, cAMP can indirectly induce NAB2 since it stim-
ulates Egr-1 promoter activity [24]. All the PKC,
MAPK and cAMP/PKA transduction systems can thus
potentially either activate or inhibit the LHβ gene
depending on the modalities of GnRH stimulation. In
contrast to the EGR-1/NAB2 system, the follistatin
gene appears to be most specifically activated through
cAMP/PKA [49].
Altogether, these complex regulatory systems sug-
gest the functional predominance within gonadotropes
of specific autoregulatory negative feedback loops
composed of genes differentially sensitive to GnRH
pulse frequency thus conferring a high dependence of
LH and FSH on the GnRH stimulatory code. Whether
similar systems also contribute to regulate expression
of gonadotropin genes or others such as the GnRHR
gene remains to be established.
Conclusion
The pecular mode of secretion of hypothalamic GnRH,
together with the unusual structure and functional
properties of the mammalian GnRHR defines a unique
mode of intercellular communication as well as
endocrine or neuroendocrine regulation. Indeed, the
gonadotrope cells are exposed to considerably variable
GnRH stimulations (from short to massive and even
sustained) that profoundly and differentially affect
gonadotropin release and gene regulation. The fact that
these actions are mediated through a desensitization-
resistant receptor implies the exclusive contribution of
post-receptor mechanisms to achieve not only the
secretory functions of gonadotropes but also the
appropriate resistance of these cells to overstimulation
which could lead to excessive secretion and hence, cell
death. Taking into account these considerations, the
function of gonadotrope cells appears surprisingly
well adapted. The two models known to date for the
activation/inactivation of gonadotropin β-subunit
genes are exemplary of such dual functionality. The
transcription factors EGR-1/NAB on the one hand, the
regulatory factors activin/follistatin on the other hand,
constitute two distinct, specific autoregulatory loops
for the LHβ and FSHβ genes, respectively. In both sys-
tems, one partner (EGR-1 or activin) is responsible for
activation, while the second (NAB or follistatin) is
responsible for inactivation of a third partner gene
(LHβ or FSHβ). In fine, the situation emphasizes the
adaptative reciprocal complementarity of both hypo-
thalamic GnRH neurons and pituitary gonadotropes to
function as an original unit mediating brain control of
the reproductive system.
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